Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416401282> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2416401282 endingPage "5" @default.
- W2416401282 startingPage "283" @default.
- W2416401282 abstract "Previous studies have demonstrated improvements in health-related quality of life in asthmatic patients after treatment with fluticasone propionate. CD30 is a marker of Th2 lymphocytes, which are key cells in the pathogenesis of allergic inflammation. There is also a soluble form of CD30 (sCD30) released by CD30+ cells. Since serum sCD30 levels are high in allergic patients, in our study we examined the possible role of fluticasone propionate in modulating sCD30 release in patients with severe allergic asthma. In addition, we evaluated a possible correlation between sCD30 and FEV1 in these patients. To this end two groups of subjects were enrolled: 20 healthy nonatopic control subjects (group A) and 20 atopic patients with severe bronchial asthma receiving fluticasone propionate at the total dosage of 1 mg/day for 8 weeks (group B). Serum samples were examined before and after the treatment period. sCD30 serum levels were determined by the commercial ELISA-kit (Dako). The limit of detection of the assay was 1 U/ml. Our data show that sCD30 basal serum levels were significantly (p <0.05) higher in patients of group B respect to group A subjects (8.35+/-4.88 vs. <1 IU/ml, respectively). In addition, we found that sCD30 serum levels were undetectable in patients of group B after fluticasone propionate therapy. In group B a positive correlation between serum sCD30 levels and FEV1 values before fluticasone propionate treatment was noted (Rho = -0.644, p <0.005). The fluticasone propionate inhibition of sCD30 release may partly explain how fluticasone propionate exerts its antiinflammatory activity, through the modulation of Th2 cells." @default.
- W2416401282 created "2016-06-24" @default.
- W2416401282 creator A5049664900 @default.
- W2416401282 creator A5058464702 @default.
- W2416401282 creator A5058914724 @default.
- W2416401282 creator A5062230470 @default.
- W2416401282 creator A5068534209 @default.
- W2416401282 date "2000-12-07" @default.
- W2416401282 modified "2023-09-27" @default.
- W2416401282 title "Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma." @default.
- W2416401282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11108439" @default.
- W2416401282 hasPublicationYear "2000" @default.
- W2416401282 type Work @default.
- W2416401282 sameAs 2416401282 @default.
- W2416401282 citedByCount "4" @default.
- W2416401282 countsByYear W24164012822015 @default.
- W2416401282 countsByYear W24164012822016 @default.
- W2416401282 countsByYear W24164012822018 @default.
- W2416401282 crossrefType "journal-article" @default.
- W2416401282 hasAuthorship W2416401282A5049664900 @default.
- W2416401282 hasAuthorship W2416401282A5058464702 @default.
- W2416401282 hasAuthorship W2416401282A5058914724 @default.
- W2416401282 hasAuthorship W2416401282A5062230470 @default.
- W2416401282 hasAuthorship W2416401282A5068534209 @default.
- W2416401282 hasConcept C126322002 @default.
- W2416401282 hasConcept C203014093 @default.
- W2416401282 hasConcept C2776042228 @default.
- W2416401282 hasConcept C2777785397 @default.
- W2416401282 hasConcept C2778024521 @default.
- W2416401282 hasConcept C2779028295 @default.
- W2416401282 hasConcept C2779306644 @default.
- W2416401282 hasConcept C2780942790 @default.
- W2416401282 hasConcept C2781212218 @default.
- W2416401282 hasConcept C71924100 @default.
- W2416401282 hasConcept C90924648 @default.
- W2416401282 hasConceptScore W2416401282C126322002 @default.
- W2416401282 hasConceptScore W2416401282C203014093 @default.
- W2416401282 hasConceptScore W2416401282C2776042228 @default.
- W2416401282 hasConceptScore W2416401282C2777785397 @default.
- W2416401282 hasConceptScore W2416401282C2778024521 @default.
- W2416401282 hasConceptScore W2416401282C2779028295 @default.
- W2416401282 hasConceptScore W2416401282C2779306644 @default.
- W2416401282 hasConceptScore W2416401282C2780942790 @default.
- W2416401282 hasConceptScore W2416401282C2781212218 @default.
- W2416401282 hasConceptScore W2416401282C71924100 @default.
- W2416401282 hasConceptScore W2416401282C90924648 @default.
- W2416401282 hasIssue "5" @default.
- W2416401282 hasLocation W24164012821 @default.
- W2416401282 hasOpenAccess W2416401282 @default.
- W2416401282 hasPrimaryLocation W24164012821 @default.
- W2416401282 hasRelatedWork W119338573 @default.
- W2416401282 hasRelatedWork W1969372887 @default.
- W2416401282 hasRelatedWork W2002872850 @default.
- W2416401282 hasRelatedWork W2040008754 @default.
- W2416401282 hasRelatedWork W2350153370 @default.
- W2416401282 hasRelatedWork W2355595675 @default.
- W2416401282 hasRelatedWork W2384677119 @default.
- W2416401282 hasRelatedWork W2793387368 @default.
- W2416401282 hasRelatedWork W3030079564 @default.
- W2416401282 hasRelatedWork W3140605304 @default.
- W2416401282 hasVolume "10" @default.
- W2416401282 isParatext "false" @default.
- W2416401282 isRetracted "false" @default.
- W2416401282 magId "2416401282" @default.
- W2416401282 workType "article" @default.